Hugo Kohnke
- Pharmacology top 0.5%
- Cardiology and Cardiovascular Medicine top 10%
- Molecular Biology
- Oncology
- Pediatrics, Perinatology and Child Health top 10%
- Co-authors
- Mia WadeliusNiclas ErikssonAnke H. Maitland‐van der ZeeAnn K. DalyJulian LeathartPatrick KestevenPeter AveryGirvan Burnside
- Topics
- Chronic Lymphocytic Leukemia Research (3 papers)Pharmacogenetics and Drug Metabolism (3 papers)Rheumatoid Arthritis Research and Therapies (3 papers)
- Partner nations
- SwedenUnited KingdomNetherlands
In The Last Decade
Hugo Kohnke
10 papers receiving 831 citations
Hit Papers
Peers
Comparison fields: 5 of 69
- Pharmacology 479
- Cardiology and Cardiovascular Medicine 214
- Molecular Biology 172
- Oncology 145
- Pediatrics, Perinatology and Child Health 113
Countries citing papers authored by Hugo Kohnke
This map shows the geographic impact of Hugo Kohnke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hugo Kohnke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hugo Kohnke more than expected).
Fields of papers citing papers by Hugo Kohnke
This network shows the impact of papers produced by Hugo Kohnke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hugo Kohnke. The network helps show where Hugo Kohnke may publish in the future.
Co-authorship network of co-authors of Hugo Kohnke
This figure shows the co-authorship network connecting the top 25 collaborators of Hugo Kohnke. A scholar is included among the top collaborators of Hugo Kohnke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hugo Kohnke. Hugo Kohnke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | [New recommendation on pharmacogenetic screening prior to 5-fluorouracil based cancer treatment - Swedish experience indicates less adverse effects and healthcare cost savings]. | 1 |
| 3 | 8 | |
| 4 | 8 | |
| 5 | 36 | |
| 6 | 14 | |
| 7 | A Randomized Trial of Genotype-Guided Dosing of Warfarinbreakdown → | 590 |
| 8 | 26 | |
| 9 | 107 | |
| 10 | 53 |
About Hugo Kohnke
Hugo Kohnke is a scholar working on Pharmacology, Genetics and Hepatology, having authored 10 papers that have together received 848 indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (3 papers), Pharmacogenetics and Drug Metabolism (3 papers) and Rheumatoid Arthritis Research and Therapies (3 papers). The work is most often cited by research in Pharmacology (479 citations), Internal Medicine (64 citations) and Cardiology and Cardiovascular Medicine (214 citations). Hugo Kohnke has collaborated with scholars based in Sweden, United Kingdom and Netherlands. Frequent co-authors include Mia Wadelius, Niclas Eriksson, Anke H. Maitland‐van der Zee, Ann K. Daly, Julian Leathart, Patrick Kesteven, Peter Avery, Girvan Burnside, Andrea Jorgensen and Toby Nicholson. Their work appears in journals such as New England Journal of Medicine, Clinical Pharmacology & Therapeutics and Clinica Chimica Acta.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.